Log in
Enquire now
Avidity Biosciences

Avidity Biosciences

Avidity Biosciences is a biotechnology company developing RNA-based therapeutics that is headquartered in San Diego, California.

OverviewStructured DataIssuesContributors

Contents

aviditybiosciences.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Oncology
Oncology
Medicine
Medicine
Healthcare
Healthcare
‌
Synthetic chemistry
Internal medicine
Internal medicine
Biotechnology
Biotechnology
Drug discovery
Drug discovery
Pharmaceutical industry
Pharmaceutical industry
...
Location
San Diego
San Diego
0
La Jolla
La Jolla
United States
United States
Switzerland
Switzerland
‌
La Jolla, Placentia, California
B2X
B2B2C
B2B2C
B2B
B2B
0
CEO
‌
Sarah Boyce
0
Founder
‌
Kent Hawryluk
Pitchbook URL
pitchbook.com/profiles.../61547-95
Legal Name
Avidity Biosciences, Inc.0
Legal classification
Corporation
Corporation
Incorporation (business)
Incorporation (business)
Date Incorporated
2012
Number of Employees (Ranges)
51 – 200
Email Address
info@aviditybio.com0
patients@aviditybio.com0
partnering@aviditybio.com0
investors@aviditybio.com0
Phone Number
+185840179000
Full Address
10975 N. Torrey Pines Road, Suite 150 La Jolla, California 92037
CIK Number
1,599,9010
Place of Incorporation
Delaware
Delaware
0
Investors
Alexandria Real Estate Equities
Alexandria Real Estate Equities
Brace Pharma Capital
Brace Pharma Capital
Eli Lilly
Eli Lilly
Tavistock Group
Tavistock Group
Eight Roads Ventures
Eight Roads Ventures
EcoR1 Capital
EcoR1 Capital
F-Prime Capital Partners
F-Prime Capital Partners
Moore Venture Partners
Moore Venture Partners
...
DUNS Number
78670869
IRS Number
461,336,9600
Founded Date
2013
0
Total Funding Amount (USD)
140,100,000
Latest Funding Round Date
November 13, 2019
Competitors
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals
Moderna Therapeutics
Moderna Therapeutics
Arcturus Therapeutics
Arcturus Therapeutics
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
CureVac
CureVac
Sarepta Therapeutics
Sarepta Therapeutics
Business Model
Commerce
Stock Symbol
RNA0
Exchange
Nasdaq
Nasdaq
Board of Directors
Troy Wilson
Troy Wilson
0
‌
Sarah Boyce
0
Edward Kaye
Edward Kaye
0
Also Known As
Avidity
Latest Funding Type
Series C
Series C
Patents Assigned (Count)
14
Country
United States
United States

Other attributes

Company Operating Status
Active
Contact Page URL
aviditybiosciences.com/con...-us/
Latest Funding Round Amount (USD)
100,000,000
Previous Name
Avidity Biosciences LLC0
Avidity NanoMedicines LLC0
SIC Code
2,8340
Ticker Symbol
RNA0

Avidity Biosciences is a developer of oligonucleotide-based therapies using a proprietary platform to design, engineer, and develop therapeutics combining the tissue selectivity of monoclonal antibodies with oligonucleotide-based therapies.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Avidity Biosciences

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us